This is an old revision of this page, as edited by Ljuvlig (talk | contribs) at 07:18, 2 June 2019 (←Created page with ''''BioInvent International''' is a Swedish research, pharmaceutical and life science company with focus on clinical development of antibody drugs for immunothera...'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
BioInvent International is a Swedish research, pharmaceutical and life science company with focus on clinical development of antibody drugs for immunotherapy against cancer. The company was founded in 1983 by Carl Borrebaeck and is listed on the Stockholm Stock Exchange since 2001. The company's partners include Bayer HealthCare, Daiichi Sankyo, Mitsubishi Tanabe and Servier.
